The activity of TPY3m as an allosteric agonist of the TSH receptor and possibly as an agonist/positive allosteric modulator (ago-PAM) became the starting point for its use to stimulate TH production and correct thyroid deficiency in T2DM. The gene discussed is TSHR; the disease is hypothyroidism.